Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Steven B. Ratoff currently holds 27,364 shares of EAGLE PHARMACEUTICALS, INC. (EGRX), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Steven B. Ratoff has been a net buyer of EGRX stock. They have purchased $844.0K and sold $750.1K worth of shares.
Steven B. Ratoff's most recent insider trade was on Apr 8, 2021, when they sold 2,340 shares at $4.42 per share.
Steven B. Ratoff serves as Executive at EAGLE PHARMACEUTICALS, INC. (EGRX). They have executed 27 insider transactions totaling $1.6M over their tenure at the company.
Steven B. Ratoff holds the position of Executive at EAGLE PHARMACEUTICALS, INC., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 20 years and currently hold a stake valued at $0.
Steven B. Ratoff has shown a buying trading pattern, with $844.0K in total purchases and $750.1K in total sales across all transactions. Their most recent activity indicates a tendency to accumulate shares.
The largest transaction by Steven B. Ratoff was on Dec 13, 2016, when they sold $652.5K worth of EGRX shares. This transaction involved 8,700 shares at $75.00 per share.
Steven B. Ratoff currently owns 27,364 shares of EAGLE PHARMACEUTICALS, INC. (EGRX), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Steven B. Ratoff's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Steven B. Ratoff has 27 Form 4 filings on record as an insider at EAGLE PHARMACEUTICALS, INC..
Set alerts for Steven B. Ratoff and 40,000+ other insiders.